TrialPsychiatry and clinical neurosciences2023

Efficacy and safety of zuranolone in Japanese adults with major depressive disorder: A double-blind, randomized, placebo-controlled, phase 2 clinical trial.

Masaki Kato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.